Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
EMA guidance · 2013-10-17Workshop on clinical investigation of new medicines for the treatment of multiple sclerosis takes place today
EMA workshop on clinical investigation of new medicines for the treatment of multiple sclerosis current event overview and discussion.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients
A completed clinical trial evaluating the prevalence of spasticity in relapsing-remitting multiple sclerosis and its impact on quality of li…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
A completed clinical trial evaluating sexual dysfunction, disability, and quality of life in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
A completed clinical trial update investigates how well the MS Functional Composite (MSFC) correlates with the Expanded Disability Status Sc…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS) [Phase 2, Phase 3]
Phase 2/3 clinical trial update evaluating armodafinil for neurocognition and cognitive fatigue in multiple sclerosis; results were posted i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
An open-label, proof-of-concept study evaluating the effects of dalfampridine withdrawal on gait and balance in people with multiple scleros…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Oral Cladribine in Early Multiple Sclerosis (MS) [Phase 3]
Phase 3 trial update for oral cladribine in early multiple sclerosis has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
A completed clinical trial evaluating whether Glatiramer Acetate (Copaxone) induces anti-inflammatory Type II monocytes in individuals with …
-
CLINICAL_TRIALS research · 2013-09-30Clinical Trial Update: A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein). [NA]
A single-center, cross-sectional study in people with multiple sclerosis investigates different types of cognitive impairment and cerebrospi…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Modafinil in Multiple Sclerosis [NA]
A completed clinical trial investigated Modafinil as a treatment for Multiple Sclerosis.
-
FDA approval · 2013-09-24FDA Approved: KESIMPTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kesimpta (ofatumumab) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS research · 2013-09-23Clinical Trial Update: Lokomat Training Effects on MS Gait Abnormalities [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lokomat robotic gait training for gait abnormalities in people with multiple sclerosis has been termin…
-
CLINICAL_TRIALS research · 2013-09-23Clinical Trial Update: Targeted Lower Extremity Joint Training [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating targeted lower extremity joint training for people with Multiple Sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis [Phase 1, Phase 2]
A clinical trial evaluates the effect of robot-assisted training on foot drop in people with Multiple Sclerosis. The Phase 1 and Phase 2 stu…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Restoration of Walking in Multiple Sclerosis Using Treadmill Training. [NA]
A completed clinical trial evaluated treadmill training as a rehabilitation approach to restore walking in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) [Phase 3]
This Phase 3 trial update reports on the safety and tolerability of Avonex (interferon beta-1a) in Chinese subjects with relapsing multiple …
-
CLINICAL_TRIALS research · 2013-09-16Clinical Trial Update: Avonex PEN Satisfaction and Patients Experience Clinical Trial
A completed study evaluating satisfaction and patient experience with Avonex PEN in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia [Phase 4]
Phase 4 trial update reporting measurement of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1a IM, com…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Stress Management for Patients With Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating stress management for patients with multiple sclerosis; the study is completed and results were posted in …
-
FDA approval · 2013-09-05FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) from Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis [Phase 2]
An extension study evaluating the efficacy and safety of Fingolimod (Gilenya) in relapsing multiple sclerosis has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis [Phase 3]
Phase 3, multicenter, open-label randomized crossover trial completed to compare subject preference for Kemstro (baclofen) versus convention…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Telephone Intervention for Pain Study (TIPS) [NA]
This entry notes the completion of the Telephone Intervention for Pain Study (TIPS), a University of Washington–sponsored clinical trial ass…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis
Validation study evaluating a hand-held dynamometer for assessing lower limb muscle strength in individuals with multiple sclerosis.
-
FDA label_change · 2013-08-20FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Tecfidera (dimethyl fumarate), resulting in a label change for this multiple sclerosi…